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This review addresses the issue of sex differences in the response to cannabinoid com-
pounds focusing mainly on behaviors belonging to the cognitive and emotional sphere.
Sexual dimorphism exists in the different components of the endocannabinoid system.
Males seem to have higher CB1 receptor binding sites than females, but females seem
to possess more efﬁcient CB1 receptors. Differences between sexes have been also
observed in the metabolic processing of THC, the main psychoactive ingredient of mar-
ijuana. The consistent dimorphism in the endocannabinoid system and THC metabolism
may justify at least in part the different sensitivity observed between male and female
animals in different behavioral paradigms concerning emotion and cognition after treat-
ment with cannabinoid compounds. On the basis of these observations, we would like to
emphasize the need of including females in basic research and to analyze results for sex
differences in epidemiological studies.
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Although the notion of sex differences in brain functionality was
already present at the end of the nineteenth century (Andreano
and Cahill, 2009), it is only in the last decade that increasing liter-
ature has supported and documented it. In fact for long, females
were under-represented or even excluded in both clinical and pre-
clinical studies. Indeed, until recently, the prevalent strategy in
animal studies was to use males only, ironically to avoid likely sex
effects.
The most characterized brain regions where functional and
structural dimorphism have been studied are the hippocampus,
amygdala, hypothalamus, and cortex, cerebral areas associated
with cognition and emotion. Besides the anatomy, also the neu-
rochemistry and physiology could differ in these areas between
males and females. For example, dopamine, serotonin, and GABA,
among others, have been shown to exhibit signiﬁcant sex differ-
ences in their metabolism (Andreano and Cahill, 2009), as well as
various neuropeptidergic systems (Bielsky et al., 2005; Kauffman,
2010). It is not surprising then that compounds acting in these
areas and through mechanisms involving these neurotransmitters
could trigger different responses in males and females.
This review addresses the issue of sex inﬂuences on the endo-
cannabinoid system both in term of differences in the components
of the system between sexes and differences in the response to
cannabinoid compounds, focusing on behaviors belonging to the
cognitive and emotional sphere.
SEX DIFFERENCES IN THE ENDOCANNABINOID SYSTEM
Very few data are available regarding sex differences in cannabi-
noid CB1 receptor density and coupling to G proteins, and fewer
ones are available on the endocannabinoid levels.
Despite this limitation, a rather clear picture arises for CB1
receptor: in all the paperswhereCB1 receptor levelsweremeasured
in both male and female animals, a higher density was observed
in males in almost all the cerebral regions analyzed (Rubino et al.,
2008; Burston et al., 2010; Mateos et al., 2010; Riebe et al., 2010).
The increase in CB1 receptor density was observed in both ado-
lescent and adult animals, however it was stronger and wider in
younger rats. For example in the adult amygdala, CB1 receptor
binding site density was higher in females than males, a differ-
ence that appears to be dependent upon the presence of estradiol,
since in ovariectomized female rats it was no longer seen (Riebe
et al., 2010). Despite the lower receptor density, however, adoles-
cent females showed the higher G protein activation after CB1
receptor stimulation in several brain areas (Rubino et al., 2008;
Burston et al., 2010), thus suggesting the presence of more efﬁcient
receptors. At adulthood, higher CB1 receptor/G protein coupling
was still present in the prefrontal cortex of female rats (Burston
et al., 2010;Mateos et al., 2010),whereas it was no longer evident in
the amygdala (Mateos et al., 2010), hypothalamus, periaqueductal
gray, ventralmidbrain, and cerebellum (Burston et al., 2010). Con-
trasting data have been reported for the hippocampus: Burston
et al. (2010) described higher CP-55,940-stimulated G protein
activation in male rats whereas Mateos et al. (2010), reported it
in females. Different hypotheses can be put forward to explain
this discrepancy: ﬁrst of all, different rat strains have been used,
Long Evans vs. Wistar rats. A different approach was employed to
assess CB1 receptor/G protein coupling, namely autoradiographic
analysis on brain sections in Mateos’ study and binding studies on
membrane samples from brain tissue in the Burston’s one. Most
importantly, in the study by Mateos et al. (2010), rats underwent
intense behavioral analysis before the biochemical studies whereas
in that of Burston they didn’t.
Sex differences in CB1 receptor density were also reported
in humans, again with men showing higher binding levels in
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early adulthood (age 18–45; Van Laere et al., 2008). Sex differ-
ences were still evident later in life (age 45–70), but while men
maintained or lost some CB1 binding sites, women increased
them throughout the brain, thus presenting higher CB1 recep-
tor levels at this speciﬁc interval of age (Van Laere et al.,
2008).
Only one paper dealt with endocannabinoid levels in adultmale
and female animals (Bradshaw et al., 2006). Among the seven
different brain areas analyzed, the authors found no signiﬁcant
differences in anandamide levels between male and female rats,
whereas 2-arachidonoylglycerol (2-AG) was higher in the female
pituitary gland and hypothalamus, but lower in the cerebellum.
When the different phases of the estrous cycle were taken into
account the picture became more complex, with ﬂuctuation of the
endocannabinoid levels among them and therefore much more
diversity between male and female rats. In neonatal rats, females
had lower amounts of the endocannabinoids 2-AG and anan-
damide in the amygdala and, accordingly, higher content of the
endocannabinoid degradation enzymes, fatty acid amid hydro-
lase and monoacylglycerol lipase than males in this cerebral area
(Krebs-Kraft et al., 2010).
SEX DIFFERENCES IN THE PHARMACOKINETICS OF
CANNABINOID COMPOUNDS
Animal studies have shown sex differences in the metabolic pro-
cessing of delta 9-tetrahydrocannabinol (THC). For example THC
was oxidized selectively to 11-OH-delta 9-THC by liver micro-
somes of female rats, a form that retains the potency of THC,
while in male rats, besides 11-OH-delta 9-THC, it was biotrans-
formed to at least three different less activemetabolites (Narimatsu
et al., 1991). Accordingly, after intraperitoneal injections of THC,
levels of its metabolites in brain tissue, including 11-OH-delta 9-
THC, the major active metabolite, were higher in females than in
males (Tseng et al., 2004). Moreover cannabinoids are lipophilic
and are sequestered in fat tissue. Adult male rats have a greater
percentage of body fat than adult females and therefore their fat
cells may retain more THC allowing a smaller amount to reach the
brain.
SEX DIFFERENCES IN THE RESPONSE TO CANNABINOID
COMPOUNDS
In viewof this consistent dimorphism in the endocannabinoid sys-
tem and THC metabolism, it is not surprising that cannabinoid
compounds, and particularly THC, might have different effects
when administered inmale or female animals.Despite this obvious
observation, very few studies have taken into account this possibil-
ity, performing the same experiments in both males and females.
Curiously enough, most of them regarded the long-term effects of
adolescent exposure to cannabinoids with particular emphasis on
cognition and emotionality.
When the object recognition test was used, adolescent exposure
to increasing doses of the synthetic cannabinoid agonist CP-55,940
for 21 days (post-natal days 30–50) induced impaired working
memory checked following a long drug-free period in both female
(O’Shea et al., 2004) and male rats (O’Shea et al., 2006). However,
the same treatment at adulthood led to long-termmemory impair-
ments in male but not female rats (O’Shea et al., 2004, 2006).
In contrast, when the spatial memory was assessed through the
Morris water maze, THC signiﬁcantly disrupted learning in the
adolescent males and females and also in adult females, whereas
it did not affect learning in adult males (Cha et al., 2007). How-
ever chronic THC during either adolescence or adulthood had no
effect on spatial learning in animals of both sexes tested after a long
drug-free period (Cha et al., 2007). Accordingly, Higuera-Matas
et al. (2009) reported that also the cannabinoid agonist CP-55,940
administered during adolescence did not affect adult performance
of animals of both sexes in the water maze. In our work, both male
and female rats showed spatial working memory deﬁcits tested in
the radial maze long after adolescent exposure to THC (Rubino
et al., 2009a,b).
As a whole, this behavioral picture seems to suggest that when-
ever the exposure to cannabinoid agonists occurs during adoles-
cence, it disrupts cognitive behaviors in both sexes if animals were
tested immediately after, whilst the presence of long-term effects
might depend upon the speciﬁc type of memory assessed and the
sex of the animals.
Besides the behavioral picture, also the molecular underpin-
nings of the cognitive impairments induced by cannabinoids
might present sexual dimorphism. For example we showed that
THC, although inducing the same behavioral deﬁcit in the radial
maze in both male and female rats, triggered a different cel-
lular alteration at the level of brain circuitries (Rubino et al.,
2009a,b). In adult female rats exposed to THC in adolescence
the spatial working memory impairment was correlated to a sig-
niﬁcant decrease in synaptophysin and PSD95 proteins in the
prefrontal cortex. Moreover, proteomic analysis of the synapto-
somes from this brain area, demonstrated the presence of less
active synapses characterized by reduced ability in maintaining
normal synaptic efﬁciency (Rubino et al., 2009a), thus suggesting
the occurrence of altered synaptic plasticity throughout the pre-
frontal cortex in THC-pre-exposed female rats. In adult male rats
chronically treatedwithTHCduring adolescence, the spatialwork-
ing memory deﬁcit was instead related to a signiﬁcant decrease in
the astroglial marker GFAP as well as in pre- and post-synaptic
protein expression (VAMP2, PSD95) and NMDA receptor lev-
els in the hippocampus. These animals also exhibited lower total
dendritic length and number as well as reduced spine density in
the hippocampal dentate gyrus (Rubino et al., 2009b), suggest-
ing that male THC pre-treated rats may establish less synaptic
contacts and/or less efﬁcient synaptic connections throughout the
hippocampus.
These data support the notion that males and females may use
differing neural paths to reach the same behavioral end point (see
for review Andreano and Cahill, 2009) and that the same THC
exposure may have different neuronal consequences in the brain
of male or female rats.
At the human level, besides the well-known notion that acute
cannabis intoxication has been associated with transient and
reversible decrements in attention, memory, and executive func-
tions (see for review Solowij and Pesa, 2010), no evidence exists
about sexual dimorphism in this dimension. Females are still
too under-represented in epidemiological studies to gain a pic-
ture of different cognitive effects after THC exposure in men and
women.
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Moreover, although few papers addressed this issue, they seem
to support the notion that adolescent female rats appear to bemore
sensitive to the long-lasting effects triggered by chronic cannabi-
noid consumption on emotional responses than males; on the
contrary, at adulthood, no sex differences are evident, or even
males appear to be the more affected in the emotional domain. In
fact, chronic CP-55,940 in adolescence impaired social interaction
in both male and female rats, however when the same treatment
was performed in adult animals, only males were affected (O’Shea
et al., 2004, 2006).Moreover,whenHU210was chronically admin-
istered in adult male and female rats, a signiﬁcant antidepressant
response was observed in both sexes (Morrish et al., 2009). In
the hole board test, which measures the propensity for novelty
anduncertainty,adolescentCP-55,940 treatment increased general
motor activity and inspective exploration in female rats, whereas
decreased explorative behavior without affecting general motor
activity in males (Biscaia et al., 2003). Finally we observed that
adolescent exposure to THC triggered the development of a com-
plex depressive-like phenotype at adulthood only in female rats,
male rats not presenting both behavioral and biochemical parame-
ters of depression (Rubino et al., 2008). Among the biochemical
parameters, the transcription factor CREB seems to be involved
in both the mechanism of action of antidepressants as well as the
disease itself (Blendy, 2006). Accordingly, adolescent THC signiﬁ-
cantly reduced pCREB in the prefrontal cortex and hippocampus
of female rats but not in males. Conversely, elevated CREB activity
in the NAc produces various depressive-like effects in rodents (see
for review Carlezon et al., 2005), and THC signiﬁcantly increased
it in the nucleus accumbens of female rats.Again,male rats showed
no changes in pCREB levels in this cerebral region (Rubino et al.,
2008).
As a whole these data seem to suggest that the adolescent
female brain is more vulnerable to the adverse effects of chronic
cannabinoid administration on emotional behavior than the adult
brain. In support of this, when the same chronic THC treat-
ment performed in adolescent female rats was administered in
adult females, it did not induce long-lasting impairment in the
emotional domain (Realini et al., 2011). The reason for this vulner-
ability is still unknown, however, possible sex steroid-dependent
differences in the sensitivity of certain neuronal processes to
cannabinoid treatment could be put forward. Accordingly, it was
reported the existence of ﬂuctuations along the ovarian cycle and
sex steroid replacement in CB1 receptor density and afﬁnity in
certain brain areas (Rodríguez de Fonseca et al., 1994; Riebe et al.,
2010), suggesting that estradiol may affect it. Estradiol elicits anx-
iolytic and antidepressant effects when injected in female rats
(Fink et al., 1998; Bodo and Rissman, 2006; Walf and Frye, 2009;
Romano-Torres and Fernández-Guasti, 2010). Estradiol-induced
changes in emotionality are sensitive to the blockade of CB1
receptors, thus suggesting that alterations in endocannabinoid
activity may contribute to estradiol’s ability to modulate mood
and affect (Hill et al., 2007). Therefore it could be speculated
that the disruption of the endocannabinoid system homeosta-
sis by exogenous administration of cannabinoid compounds in
adolescence, a period where hormonal changes leading to sex-
ual maturation occur, might impact emotionality in developing
females.
As already observed for cognitive studies, no clear evi-
dence exists about sexual dimorphism in emotional responses
to cannabinoids at human levels. However in some epidemi-
ological studies, although not clear stated, a gender difference
might be found. For example, in a study where withdrawal symp-
toms after cessation of cannabis use was assessed, the symptoms
formed two factors, one characterized by weakness, hypersomnia,
and psychomotor retardation, and the second by anxiety, rest-
lessness, depression, and insomnia (Hasin et al., 2008). When
the authors examined the relationship of demographic charac-
teristics to cannabis withdrawal symptoms in the full sample
of frequent cannabis users, gender was associated with both
the weakness symptoms and the anxiety/depression symptoms.
Moreover, in an Indigenous Arnhem Land community sample,
a strong association between heavy cannabis use in young peo-
ple and moderate–severe depressive symptoms was found, and
the rates of depression were nearly a third of females and one
in six males reporting moderate–severe symptoms (Lee et al.,
2008).
On the other hand, clinical data seem to indicate that the
endocannabinoid system may be disturbed in affective disease,
especially in females (Hill et al., 2008). Serum 2-AG content was
signiﬁcantly decreased in female patients diagnosed with major
depression, and this decrease was correlated signiﬁcantly and
negatively with duration of the depressive episode (Hill et al.,
2008).
Together these observations suggest the potential utility of tar-
geting the endocannabinoid system for the treatment of affective
disorders in females.
Finally, in addition to cognitive and emotional ones, other
cannabinoid effects have been also shown to be sexually dimor-
phic. Cannabinoids are more potent and in some cases more
efﬁcacious in females than males in producing antinociception
and altering movement (Craft, 2005). In Long–Evans and Lis-
ter Hooded rats, females showed a signiﬁcant faster acquisi-
tion of WIN 55212-2 self-administration and maintained higher
levels of responding than males, suggesting that cannabinoids
might be more reinforcing for females than males (Fattore et al.,
2007). Ovarian hormones might be involved in the modulation
of the reinforcing effect of cannabinoids, in fact, when com-
pared to intact females, a lower percentage of ovariectomized
females acquired and maintained stable drug intake (Fattore et al.,
2007).
CONCLUSION
The data here reported clearly suggest the presence of sex differ-
ences in behavioral and neurochemical responses to cannabinoid
compounds. The involvement of sex steroid hormones in most
of the sex differences in cannabinoid-induced behavioral effects
has been already put forward and appears to be the more likely
explanation (González et al., 2000; Viveros et al., 2010).
Intriguingly, a very recent work even suggested the involve-
ment of cannabinoid signaling in the establishment of normal sex
differences in the brain (Krebs-Kraft et al., 2010). The authors
demonstrated that early exposure to cannabinoids masculinizes
social play in females without altering this behavior in males.
The likely cellular mechanism for this sexual differentiation of
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the developing brain and behavior might be the regulation of cell
proliferation and cell type in the developing amygdala.
On the basis of these observations, we would like to empha-
size the need of including females in basic research and to analyze
results for sex differences in epidemiological studies. Moreover,
when acute cannabinoid effects are taken into account it would
be very useful also to discriminate among the different female
hormonal status. As a whole these data will help to better under-
stand the therapeutic possibilities of the endocannabinoid system
and to better exploit them, perhaps in a sex-dependent manner.
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